Miller Robert E

Insider CIK 1367082 · OCLS Chief Financial Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
SNOA Sonoma Pharmaceuticals, In	H Expire deriv	2019-01-14	2019-01-15	5,357	—	$0	198,443	SEC↗
SNOA Sonoma Pharmaceuticals, In	H Expire deriv	2019-01-14	2019-01-15	357	—	$0	198,086	SEC↗
SNOA Sonoma Pharmaceuticals, In	H Expire deriv	2019-01-14	2019-01-15	5,000	—	$0	193,086	SEC↗
SNOA Sonoma Pharmaceuticals, In	H Expire deriv	2019-01-14	2019-01-15	1,785	—	$0	191,301	SEC↗
SNOA Sonoma Pharmaceuticals, In	H Expire deriv	2019-01-14	2019-01-15	4,285	—	$0	187,016	SEC↗
SNOA Sonoma Pharmaceuticals, In	H Expire deriv	2019-01-14	2019-01-15	5,351	—	$0	181,665	SEC↗
SNOA Sonoma Pharmaceuticals, In	H Expire deriv	2019-01-14	2019-01-15	26,020	—	$0	155,645	SEC↗
SNOA Sonoma Pharmaceuticals, In	H Expire deriv	2019-01-14	2019-01-15	7,912	—	$0	147,733	SEC↗
SNOA Sonoma Pharmaceuticals, In	H Expire deriv	2019-01-14	2019-01-15	50,000	—	$0	97,733	SEC↗
SNOA Sonoma Pharmaceuticals, In	H Expire deriv	2019-01-14	2019-01-15	30,000	—	$0	67,733	SEC↗
SNOA Sonoma Pharmaceuticals, In	H Expire deriv	2019-01-14	2019-01-15	67,733	—	$0	0	SEC↗
SNOA Sonoma Pharmaceuticals, In	H Expire deriv	2019-01-14	2019-01-15	5,271	—	$0	203,800	SEC↗
SNOA Sonoma Pharmaceuticals, In	A Award deriv	2018-07-20	2018-07-24	67,733	—	$0	209,071	SEC↗
SNOA Sonoma Pharmaceuticals, In	P Buy	2018-03-13	2018-03-14	1,200	$4.10	$4.9K	18,868	SEC↗
SNOA Sonoma Pharmaceuticals, In	P Buy	2018-03-12	2018-03-13	1,200	$4.03	$4.8K	16,468	SEC↗
SNOA Sonoma Pharmaceuticals, In	P Buy	2018-03-12	2018-03-14	1,200	$4.03	$4.8K	17,668	SEC↗
SNOA Sonoma Pharmaceuticals, In	P Buy	2018-03-09	2018-03-13	1,200	$3.90	$4.7K	15,268	SEC↗
SNOA Sonoma Pharmaceuticals, In	P Buy	2017-11-29	2017-11-30	1,290	$5.02	$6.5K	14,068	SEC↗
SNOA Sonoma Pharmaceuticals, In	P Buy	2017-11-29	2017-11-30	500	$5.03	$2.5K	12,778	SEC↗
SNOA Sonoma Pharmaceuticals, In	P Buy	2017-11-21	2017-11-24	500	$5.04	$2.5K	12,278	SEC↗
SNOA Sonoma Pharmaceuticals, In	P Buy	2017-11-21	2017-11-24	1,500	$5.03	$7.5K	11,778	SEC↗
SNOA Sonoma Pharmaceuticals, In	P Buy	2017-08-10	2017-08-14	2,264	$5.30	$12.0K	10,728	SEC↗
SNOA Sonoma Pharmaceuticals, In	A Award	2017-06-29	2017-06-30	4,124	—	$0	20,088	SEC↗
SNOA Sonoma Pharmaceuticals, In	A Award deriv	2017-04-03	2017-04-05	30,000	—	$0	140,866	SEC↗
SNOA Sonoma Pharmaceuticals, In	P Buy	2017-03-09	2017-03-13	250	$7.14	$1.8K	8,464	SEC↗
SNOA Sonoma Pharmaceuticals, In	P Buy	2017-03-09	2017-03-13	250	$6.97	$1.7K	7,964	SEC↗
SNOA Sonoma Pharmaceuticals, In	P Buy	2017-03-09	2017-03-13	250	$6.96	$1.7K	8,214	SEC↗
SNOA Sonoma Pharmaceuticals, In	P Buy	2017-03-08	2017-03-09	750	$6.97	$5.2K	7,714	SEC↗
SNOA Sonoma Pharmaceuticals, In	P Buy	2017-03-08	2017-03-09	250	$6.81	$1.7K	6,964	SEC↗
SNOA Sonoma Pharmaceuticals, In	P Buy	2016-12-08	2016-12-12	5,000	$4.86	$24.3K	6,714	SEC↗
OCLS Oculus Innovative Sciences	A Award deriv	2016-11-30	2016-12-02	50,000	—	$0	110,866	SEC↗
OCLS Oculus Innovative Sciences	A Award	2016-11-30	2016-12-02	15,593	—	$0	15,964	SEC↗
OCLS Oculus Innovative Sciences	A Award deriv	2015-08-21	2015-08-25	40,000	$1.16	$46.4K	308,041	SEC↗
OCLS Oculus Innovative Sciences	A Award deriv	2014-03-04	2014-03-06	130,105	—	$0	247,435	SEC↗
OCLS Oculus Innovative Sciences	A Award deriv	2013-09-19	2013-09-20	26,756	—	$0	117,330	SEC↗
OCLS Oculus Innovative Sciences	A Award deriv	2012-08-24	2012-08-27	150,000	—	$0	852,064	SEC↗
OCLS Oculus Innovative Sciences	A Award deriv	2012-03-07	2012-03-09	62,500	—	$0	702,064	SEC↗